Literature DB >> 28938952

APOL1 and blood pressure changes in young adults.

Girish N Nadkarni1, Steven G Coca2.   

Abstract

APOL1 risk variants have been shown to be associated with kidney disease and hypertension. In this study, Chen and colleagues assess the association of these risk variants with longitudinal blood pressure in young adults. We review the current literature on association of these alleles with blood pressure and propose future directions to resolve the existing controversies.
Copyright © 2017 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28938952     DOI： 10.1016/j.kint.2017.05.030

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry.

Authors:  Kimberly J Reidy; Rebecca Hjorten; Rulan S Parekh
Journal:  Curr Opin Pediatr       Date:  2018-04       Impact factor: 2.856

2.  Associations between APOL1 genetic variants and blood pressure in African American mothers and children from a U.S. pregnancy cohort: Modification by air pollution exposures.

Authors:  Yu Ni; Claire L Simpson; Robert L Davis; Adam A Szpiro; Catherine J Karr; Csaba P Kovesdy; Rebecca C Hjorten; Frances A Tylavsky; Nicole R Bush; Kaja Z LeWinn; Cheryl A Winkler; Jeffrey B Kopp; Yoshitsugu Obi
Journal:  Environ Res       Date:  2022-03-28       Impact factor: 8.431

Review 3.  Apolipoprotein L1 nephropathies: 2017 in review.

Authors:  Jeffrey B Kopp; Hila Roshanravan; Koji Okamoto
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-05       Impact factor: 2.894

4.  APOL1 Risk Genotypes Are Associated With Early Kidney Damage in Children in Sub-Saharan Africa.

Authors:  Pepe M Ekulu; Agathe B Nkoy; Dieumerci K Betukumesu; Michel N Aloni; Jean Robert R Makulo; Ernest K Sumaili; Eric M Mafuta; Mohamed A Elmonem; Fanny O Arcolino; Faustin N Kitetele; François B Lepira; Lambertus P van den Heuvel; Elena N Levtchenko
Journal:  Kidney Int Rep       Date:  2019-04-11

5.  Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers.

Authors:  Patrick N Cunningham; Zhiying Wang; Megan L Grove; Rhonda M Cooper-DeHoff; Amber L Beitelshees; Yan Gong; John G Gums; Julie A Johnson; Stephen T Turner; Eric Boerwinkle; Arlene B Chapman
Journal:  PLoS One       Date:  2019-09-18       Impact factor: 3.240

6.  Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country.

Authors:  Carlos E Duran; Alejandro Ramírez; Juan G Posada; Johanna Schweineberg; Liliana Mesa; Harry Pachajoa; Mayra Estacio; Eliana Manzi; Vanessa Aros; Lorena Díaz; Victor H Garcia
Journal:  Int J Nephrol       Date:  2019-12-18

Review 7.  The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.

Authors:  Parnaz Daneshpajouhnejad; Jeffrey B Kopp; Cheryl A Winkler; Avi Z Rosenberg
Journal:  Nat Rev Nephrol       Date:  2022-02-25       Impact factor: 42.439

8.  Association of impaired kidney function with mortality in rural Uganda: results of a general population cohort study.

Authors:  Robert Kalyesubula; Isaac Sekitoleko; Keith Tomlin; Christian Holm Hansen; Billy Ssebunya; Ronald Makanga; Moses Kwizera Mbonye; Janet Seeley; Liam Smeeth; Robert Newton; Laurie A Tomlinson
Journal:  BMJ Open       Date:  2022-04-26       Impact factor: 3.006
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.